Deals, Partnering

Daiichi Sankyo to launch products in Mexico through Ranbaxy Laboratories

Posted on 11 February 2010

Tags: , ,

Additionally, the companies have agreed to promote prasugrel, an anti-platelet co-developed by Daiichi Sankyo and Eli Lilly and Company, in Mexico. Prasugrel will be co-promoted by Lilly's affiliate in Mexico.

Print Friendly, PDF & Email

Leave a Reply